Literature DB >> 23511909

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.

Rafael Tabarés-Seisdedos1, John L Rubenstein.   

Abstract

Inverse comorbidity is a lower-than-expected probability of disease occuring in individuals who have been diagnosed with other medical conditions. Emerging evidence points to inverse cancer comorbidity in people with certain CNS disorders. In this Opinion article, we discuss the evidence for this intriguing association and possible underlying mechanisms. We believe that this association is an invaluable opportunity to gain insight into the pathogenesis of these diseases, and understanding why certain individuals with CNS disorders are protected against many different types of cancer could help to develop new and improved treatments.

Entities:  

Mesh:

Year:  2013        PMID: 23511909     DOI: 10.1038/nrn3464

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  148 in total

1.  Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: molecular basis for the anticancer effect of these molecules.

Authors:  Martina Margheri; Nicola Pacini; Alessia Tani; Daniele Nosi; Roberta Squecco; Aida Dama; Erico Masala; Fabio Francini; Sandra Zecchi-Orlandini; Lucia Formigli
Journal:  Eur J Pharmacol       Date:  2012-02-21       Impact factor: 4.432

2.  Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates.

Authors:  D Lawrence; C D Holman; A V Jablensky; T J Threlfall; S A Fuller
Journal:  Acta Psychiatr Scand       Date:  2000-05       Impact factor: 6.392

3.  Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Authors:  H Hasle; I H Clemmensen; M Mikkelsen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

4.  Incidence of cancer among persons with schizophrenia and their relatives.

Authors:  D Lichtermann; J Ekelund; E Pukkala; A Tanskanen; J Lönnqvist
Journal:  Arch Gen Psychiatry       Date:  2001-06

5.  Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.

Authors:  Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

6.  Skin cancer in people with multiple sclerosis: a record linkage study.

Authors:  M J Goldacre; V Seagroatt; D Yeates; E D Acheson
Journal:  J Epidemiol Community Health       Date:  2004-02       Impact factor: 3.710

Review 7.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 8.  Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer.

Authors:  R Tabarés-Seisdedos; J L R Rubenstein
Journal:  Mol Psychiatry       Date:  2009-02-10       Impact factor: 15.992

9.  MicroRNAs in cancers and neurodegenerative disorders.

Authors:  Yoshimasa Saito; Hidetsugu Saito
Journal:  Front Genet       Date:  2012-09-26       Impact factor: 4.599

10.  Sleep and circadian rhythm disruption in schizophrenia.

Authors:  Katharina Wulff; Derk-Jan Dijk; Benita Middleton; Russell G Foster; Eileen M Joyce
Journal:  Br J Psychiatry       Date:  2011-12-22       Impact factor: 9.319

View more
  53 in total

1.  Association of cancer and Alzheimer's disease risk in a national cohort of veterans.

Authors:  Laura Frain; David Swanson; Kelly Cho; David Gagnon; Kun Ping Lu; Rebecca A Betensky; Jane Driver
Journal:  Alzheimers Dement       Date:  2017-07-12       Impact factor: 21.566

2.  Perspective: Neuroregenerative Nutrition.

Authors:  Dennis A Steindler; Brent A Reynolds
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

Review 3.  Unraveling genetic origin of aging-related traits: evolving concepts.

Authors:  Alexander M Kulminski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

4.  Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.

Authors:  Juan Liu; Cen Zhang; Hao Wu; Xiao-Xin Sun; Yanchen Li; Shan Huang; Xuetian Yue; Shou-En Lu; Zhiyuan Shen; Xiaoyang Su; Eileen White; Bruce G Haffty; Wenwei Hu; Zhaohui Feng
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 5.  A review of connectivity map and computational approaches in pharmacogenomics.

Authors:  Aliyu Musa; Laleh Soltan Ghoraie; Shu-Dong Zhang; Galina Glazko; Olli Yli-Harja; Matthias Dehmer; Benjamin Haibe-Kains; Frank Emmert-Streib
Journal:  Brief Bioinform       Date:  2018-05-01       Impact factor: 11.622

Review 6.  Biomechanisms of Comorbidity: Reviewing Integrative Analyses of Multi-omics Datasets and Electronic Health Records.

Authors:  N Pouladi; I Achour; H Li; J Berghout; C Kenost; M L Gonzalez-Garay; Y A Lussier
Journal:  Yearb Med Inform       Date:  2016-11-10

7.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

8.  Alzheimer's disease and cancer: the need of putting research into context with previous published systematic reviews.

Authors:  Ferrán Catalá-López; Rafael Tabarés-Seisdedos
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-21       Impact factor: 4.553

9.  Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity.

Authors:  Daniela P Ponce; Felipe Salech; Carol D SanMartin; Monica Silva; Chengjie Xiong; Catherine M Roe; Mauricio Henriquez; Andrew F Quest; Maria I Behrens
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

10.  Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, cancer, and neurodegenerative disorders: insights on mechanisms from the Long Life Family Study.

Authors:  Alexander M Kulminski; Konstantin G Arbeev; Irina Culminskaya; Svetlana V Ukraintseva; Eric Stallard; Michael A Province; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.